Top Device Research Payments: PARTNER II, Cardio, Neuro, Dx Device Trials Highest In 2014
This article was originally published in The Pink Sheet Daily
The transcatheter aortic valve PARTNER II study, several stent trials, and studies looking at diagnostic tools and neurological devices dominated the top ten trials by total payment to clinical investigators in 2014, according to an analysis of CMS' Open Payments database.
You may also be interested in...
The October workshop will focus discussion on clinical study trial designs, patient populations, and patient selection methods, as well as study endpoints for devices targeting ischemic stroke, FDA says.
In patients implanted with drug-eluting stents, dual antiplatelet drug therapy beyond one year significantly reduces the risks of stent thrombosis and major adverse cardiovascular and cerebrovascular events compared to aspirin alone, but also increase the risk of bleeding, the Dual Antiplatelet Therapy Trial show.
Recent data and study announcements in cardiac, neuro and diabetes.